VERA (Vera Therapeutics) Tariff Resilience Score: 5/10 (As of Jul. 05, 2026)


VERA Vera Therapeutics Inc VERA
34 GF Score
Price $41.20
! 3 Warning Signs
View Full Analysis

What is Vera Therapeutics Tariff Resilience Score?

Vera Therapeutics VERA -3.42% 34 Tariff Resilience Score is 5 as of Jul. 05, 2026. GuruFocus rates VERA with a GF Score™ of 34/100. The stock has 3 warning signs investors should review. Among 1,373 Biotechnology companies, Vera Therapeutics ranks better than 62.27% on this metric.

Vera Therapeutics has the Tariff Resilience Score of 5, which implies that the company might have Average Resilient.

Vera Therapeutics has Vera's pharmaceutical focus involves global supply chains for raw materials. While tariffs on drugs are limited, supply chain disruptions can impact costs. Mitigation through alternative suppliers is possible.

Tariff Resilience Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more.

The company's exposure to international trade tariffs based on these criteria:

1. Global supply chain dependencies
2. Manufacturing locations versus sales markets
3. Import/export balance and percentage of revenue
4. Historical impact from previous tariff changes
5. Available mitigation strategies (alternative suppliers, pricing power)
6. Industry-specific tariff exemptions or vulnerabilities

Based on the research, GuruFocus believes Vera Therapeutics might have Average Resilient.

Vera Therapeutics  (NAS:VERA) Tariff Resilience Score Explanation

The Tariff Resilience Score ranges from 0 to 10, with 10 as the most resilient. GuruFocus divided Moat Score into following 3 categories:

Tariff Resilience Score Resilience Level
7 - 10Highly Resilient
4 - 6Average Resilient
0 - 3Highly Vulnerable

Vera Therapeutics Tariff Resilience Score Related Terms

VERA vs RARE, IRON, QURE: Tariff Resilience Score Comparison

For the Biotechnology subindustry, Vera Therapeutics's Tariff Resilience Score, along with its competitors' market caps and Tariff Resilience Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Vera Therapeutics Tariff Resilience Score vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Vera Therapeutics's Tariff Resilience Score distribution charts can be found below:

* The bar in red indicates where Vera Therapeutics's Tariff Resilience Score falls into.


VERA
34GF Score
Vera Therapeutics Inc VERA
Tariff Resilience Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Tariff Resilience Score of 5 mean?
Vera Therapeutics (VERA) has a Tariff Resilience Score of 5 as of Jul. 05, 2026. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. According to the industry distribution chart, Vera Therapeutics ranks #518 out of 1373 companies in the Biotechnology industry, placing it in the top 37.7%.
Is Vera Therapeutics' Tariff Resilience Score too high?
Vera Therapeutics' current Tariff Resilience Score is 5. The Biotechnology industry median Tariff Resilience Score is 4.00. Vera Therapeutics' value of 5 is 25% above this industry median. Based on the distribution chart, Vera Therapeutics ranks #518 out of 1373 companies in the Biotechnology industry, which is above the industry midpoint. Overall, Vera Therapeutics has a GF Score™ of 34/100, reflecting its overall financial health beyond just this single metric.
How does Vera Therapeutics' Tariff Resilience Score compare to RARE and IRON?
According to the Biotechnology industry distribution chart, Vera Therapeutics ranks #518 out of 1373 companies for Tariff Resilience Score. This puts Vera Therapeutics in the upper half of its industry. The industry median Tariff Resilience Score is 4.00. Vera Therapeutics' value of 5 is 25% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Tariff Resilience Score for a Biotechnology company?
The median Tariff Resilience Score among Biotechnology companies is 4.00, based on 1,373 companies in the industry. Companies in the top quartile (top 25%) have a Tariff Resilience Score significantly above this median, while those in the bottom quartile fall well below. However, Tariff Resilience Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Vera Therapeutics's current Tariff Resilience Score of 5 is 25% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Tariff Resilience Score mean?
A high Tariff Resilience Score can signal that a stock is expensive relative to its fundamentals. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. For the Biotechnology industry, the median Tariff Resilience Score is 4.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Vera Therapeutics's current Tariff Resilience Score is 5. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vera Therapeutics stock overvalued right now?
Vera Therapeutics (VERA) has a current Tariff Resilience Score of 5. The current Tariff Resilience Score is 5 and 25% above the Biotechnology industry median of 4.00. Vera Therapeutics' overall GF Score™ is 34/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Tariff Resilience Score calculated?
Tariff Resilience Score is calculated from a company's financial statements. For Vera Therapeutics (VERA), the current Tariff Resilience Score is 5 as of Jul. 05, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Vera Therapeutics Business Description

Address 2000 Sierra Point Parkway, Suite 1200, Brisbane, CA, USA, 94005
Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator and a proliferation-inducing ligand, which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases.
34GF Score

Get the complete analysis for VERA

Tariff Resilience Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$41.20
Price